New biomarkers in an acute model of live Escherichia coli-induced sepsis in pigs

Scandinavian Journal of Immunology

Volumn 68, Issue 1, 2008, Pages 75-84

  Castellheim, A ^a   Thorgersen, E B ^a   Hellerud, B C ^a   Pharo, A ^a   Johansen, H T ^b   Brosstad, F ^c   Gaustad, P ^a   Brun, H ^a   Fosse, E ^a   Tonnessen T I ^a   Nielsen, E W ^d,e   Mollnes, T E ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d NORDLAND HOSPITAL   (Norway)

^e UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; THROMBIN ANTITHROMBIN COMPLEX; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; CAPILLARY LEAK SYNDROME; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESCHERICHIA COLI; HEART RATE; HEMODYNAMICS; LUNG ARTERY PRESSURE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SWINE; VASCULAR ENDOTHELIUM;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; HEMODYNAMICS; INFLAMMATION MEDIATORS; INTERLEUKIN-12; MATRIX METALLOPROTEINASE 9; SEPSIS; SWINE;

EID: 44849139178     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02122.x     Document Type: Article

References (38)

1. Cohen J. The immunopathogenesis of sepsis. Nature 2002 420 : 885 91.
2. Opal SM. Severe sepsis and septic shock: defining the clinical problem. Scand J Infect Dis 2003 35 : 529 34.
3. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992 20 : 864 74.
4. Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003 31 : 1250 6.
5. Esteban A, Frutos-Vivar F, Ferguson ND et al. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med 2007 35 : 1284 9.
6. Engel C, Brunkhorst FM, Bone HG et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 2007 33 : 606 18.
7. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007 35 : 1244 50.
8. Riedemann NC, Guo RF, Ward PA. The enigma of sepsis. J Clin Invest 2003 112 : 460 7.
9. Levi M, Opal SM. Coagulation abnormalities in critically ill patients. Crit Care 2006 10 : 222.
10. Netea MG, van der Meer JW, van DM, Kullberg BJ. Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing? Trends Immunol 2003 24 : 254 8.
11. Kayser FH. Bacteria as human pathogens. In : Kayser FH, Bienz KA, Eckert J, Zinkernagel RM, eds. Medical Microbiology. Stuttgart. Georg Thieme Verlag, 2005 : 229 346.
12. Vincent JL, Sakr Y, Sprung CL et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006 34 : 344 53.
13. Mokady D, Gophna U, Ron EZ. Virulence factors of septicemic Escherichia coli strains. Int J Med Microbiol 2005 295 : 455 62.
14. Kim BY, Kang J, Kim KS. Invasion processes of pathogenic Escherichia coli. Int J Med Microbiol 2005 295 : 463 70.
15. Kim KS. Escherichia coli translocation at the blood-brain barrier. Infect Immun 2001 69 : 5217 22.
16. von BH, Marre R. Antimicrobial resistance of Escherichia coli and therapeutic implications. Int J Med Microbiol 2005 295 : 503 11.
17. Barboni B, Turriani M, Galeati G et al. Vascular endothelial growth factor production in growing pig antral follicles. Biol Reprod 2000 63 : 858 64.
18. Jansen JH, Hogasen K, Mollnes TE. Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease). Am J Pathol 1993 143 : 1356 65.
19. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980 102 : 196 202.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970 227 : 680 5.
21. Makowski GS, Ramsby ML. Calibrating gelatin zymograms with human gelatinase standards. Anal Biochem 1996 236 : 353 6.
22. Dellinger RP. Cardiovascular management of septic shock. Crit Care Med 2003 31 : 946 55.
23. Winkler GC. Pulmonary intravascular macrophages in domestic animal species: review of structural and functional properties. Am J Anat 1988 181 : 217 34.
24. Levy MM. The electrocardiogram for sepsis: how close are we? Crit Care 2007 11 : 144.
25. Yano K, Liaw PC, Mullington JM et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 2006 203 : 1447 58.
26. Pickkers P, Sprong T, Eijk L, Hoeven H, Smits P, Deuren M. Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability. Shock 2005 24 : 508 12.
27. Kang BY, Kim TS. Targeting cytokines of the interleukin-12 family in autoimmunity. Curr Med Chem 2006 13 : 1149 56.
28. Goriely S, Goldman M. The interleukin-12 family: new players in transplantation immunity? Am J Transplant 2007 7 : 278 84.
29. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006 69 : 562 73.
30. Dubois B, Starckx S, Pagenstecher A, Oord J, Arnold B, Opdenakker G. Gelatinase B deficiency protects against endotoxin shock. Eur J Immunol 2002 32 : 2163 71.
31. Paemen L, Jansen PM, Proost P et al. Induction of gelatinase B and MCP-2 in baboons during sublethal and lethal bacteraemia. Cytokine 1997 9 : 412 5.
32. Coggins MP, Bloch KD. Nitric oxide in the pulmonary vasculature. Arterioscler Thromb Vasc Biol 2007 27 : 1877 85.
33. Mehta S, Javeshghani D, Datta P, Levy RD, Magder S. Porcine endotoxemic shock is associated with increased expired nitric oxide. Crit Care Med 1999 27 : 385 93.
34. Mollnes TE, Redl H, Hogasen K et al. Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC). Clin Exp Immunol 1993 91 : 295 300.
35. Esmon CT. Why do animal models (sometimes) fail to mimic human sepsis? Crit Care Med 2004 32 : S219 22.
36. Goldfarb RD, Dellinger RP, Parrillo JE. Porcine models of severe sepsis: emphasis on porcine peritonitis. Shock 2005 24 (Suppl. 1 75 81.
37. Cross AS, Opal SM, Sadoff JC, Gemski P. Choice of bacteria in animal models of sepsis. Infect Immun 1993 61 : 2741 7.
38. Marshall JC, Deitch E, Moldawer LL, Opal S, Redl H, van der PT. Preclinical models of shock and sepsis: what can they tell us? Shock 2005 24 (Suppl. 1 1 6.